Novartis slashes 1,400 jobs in US

Swiss pharmaceutical giant Novartis will cut 1,400 sales jobs in the United States by January 1, 2011, it has been announced.

This content was published on December 1, 2010 - 09:43 and agencies

The company said it would cut the jobs in its general medicines business, as sales at that business will be hurt after the patent on its high blood pressure drug Diovan expires.

Novartis said it planned to focus more resources on its primary care and speciality care businesses.

The company expects to take $85 million (SFr85.2 million) in one-time charges associated with the job cuts. It did not say how much money it expects to save.

The marketing exclusivity on Diovan expired on Monday and the patents protecting Diovan and related products start to expire in March 2012.

Novartis said it has 6,449 employees in its US general medicines business. It has 18,519 employees in the US and about 100,000 worldwide. Novartis' s US operations are based in East Hanover, New Jersey.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.